Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
Diabetes2Care a consortium around Diavantis B.V. has set of to develop an app that enables people with type 2 diabetes to take control and more responsibility for their own health. The Discret Technology and
-
automized positional therapy. We seek a postdoctoral researcher who is interested in Developing Data-driven control solutions for medical applications. Investigate the use of machine learning-based algorithms
-
for targeted exosome analysis which can also be applied to other volume-limited samples. This position is part of the EU-funded DRAGON project, which brings together biomedical and clinical partners from Italy
-
or strengthened for regional innovation policies? With this line of research, the postdoctoral researcher will contribute to our activities in the INTERREG project ‘PERSIST’ (50% of the position). In PERSIST, 9
-
out companies based on technologies developed in the research group. What we offer We offer a full-time position for initially one year. After positive evaluation of the progress of the research
-
this position will be to provide in vitro biochemical, biophysical and structural data from novel mutants of the EGFR kinase domain to drive and validate algorithmic development. Organisation The vacancy is
-
reviews. This postdoctoral position offers a unique chance to research and improve teaching quality and teacher development. You will further develop, test, and refine RIDE across multiple faculties
-
position offers a unique platform to make a lasting impact at the intersection of health policy, environmental sustainability, and societal well-being. You will: Work in a supportive, interdisciplinary team
-
an interdisciplinary team focused on real-world impact appeal to you? Then this position at Wageningen University might be just for you! Function For our research line on Healthy Lifestyle through Data Science, Machine
-
Organisation Job description Applications are invited for a fully-funded Postdoctoral researcher position for two years in the research group of Dr Danny Incarnato, at the Groningen Biomolecular